PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA.\', \'Program in Cellular and Molecular Medicine, Boston Children\'s Hospital, Boston, MA, USA.\', \'Program in Cellular and Molecular Medicine, Boston Children\'s Hospital, Boston, MA, USA. judy.lieberman@childrens.harvard.edu.\', \'Department of Pediatrics, Harvard Medical School, Boston, MA, USA. judy.lieberman@childrens.harvard.edu.\', \'Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA. wu@crystal.harvard.edu.\', \'Program in Cellular and Molecular Medicine, Boston Children\'s Hospital, Boston, MA, USA. wu@crystal.harvard.edu.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1038/s41577-021-00588-x
?:doi
?:hasPublicationType
?:journal
  • Nature reviews. Immunology
is ?:pmid of
?:pmid
?:pmid
  • 34373622
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • Inflammasome activation at the crux of severe COVID-19.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all